527
Views
56
CrossRef citations to date
0
Altmetric
Articles

Myopathies related to systemic sclerosis: a case–control study of associated clinical and immunological features

, , , , , , , , , , , & show all
Pages 498-505 | Accepted 14 Mar 2010, Published online: 20 Aug 2010
 

Abstract

Objective: Little is known about systemic sclerosis (SSc)-related myopathy. We aimed to compare the clinical and immunological features of SSc patients with or without associated myopathy.

Methods: Forty SSc patients with myopathy, defined by myalgia or muscle weakness associated with creatine kinase (CK) more than five times the upper limit range or myopathic electromyography (EMG) or abnormal myopathology, were identified from the records of four French hospital centres. For each patient, we selected two SSc controls matched for cutaneous SSc form, sex, age at SSc onset, and disease duration. We performed a case–control study testing clinical and immunological SSc-related features for association with myopathy by conditional logistic regression.

Results: Muscle and SSc features of patients with myopathy did not differ significantly among the four centres of origin. Only four (10%) patients with SSc-associated myopathy had anti-polymyositis-scleroderma (PM-Scl) antibodies. Case–control univariate analysis revealed that reduced forced vital capacity (FVC) [odds ratio (OR) 3.0, 95% confidence interval (CI) 1.3–34.9], heart involvement, defined as clinical congestive heart failure, left ventricular ejection fraction (LVEF) < 60%, arrhythmia or conductive abnormalities (OR 2.9, 95% CI 1.3–6.5), and scleroderma renal crisis (OR 3.0, 95% CI 1.3–34.9) were significantly more frequent in patients with myopathy than in controls. Two autoantibodies were more frequent in patients with myopathy: anti-PM-Scl (OR 5.0, 95% CI 1.1–23.9) and anti-RNP (OR 6.9, 95% CI 1.1–64.4). Multivariate analysis retained two variables associated positively with myopathy [reduced FVC (OR 3.1, 95% CI 1.3–9.8) and heart involvement (OR 2.5, 95% CI 1.1–7.1)], while anti-centromere antibodies were associated negatively (OR 0.11, 95% CI 0.03–0.53).

Conclusion: Heart monitoring of SSc patients with myopathy should be undertaken regularly because of the association of myocardial and skeletal myopathies in such patients.

Acknowledgements

We thank the clinicians who referred patients to us: Drs E. Arlet-Suau (CHU Purpan, Toulouse, France), P Célérier (CH Le Mans, France), J F Dervin (CH Compiègnes, France), J Emmerich (Hopital Européen Georges Pompidou, Paris, France), C Halimi (CH Senlis, France), I Jarrin (CHU Pointe à Pitre, French Antillas), Y Hatron (CHRU Lille, France), J Jouquan (CHU Brest, France), P Lanoux (CH Charleville-Mezières, France), M Mougeot-Martin (CHU Laennec, Creil, France), P Muller (CHU Pointe à Pitre, French Antillas), J Ninet (CH Edouard Herriot, Lyon, France), J Pourrat (CHU Purpan, Toulouse, France), J Simon, and R Viraben (CHU Purpan, Toulouse, France).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 171.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.